Assembly Biosciences ASMB
NASDAQ ASMB
$22.98 -0.51 (-2.17%)
At close: Oct 1, 2026 · 4:00 PM EDT

Assembly Biosciences (ASMB) Cash from Financing Activities (2010 - 2026)

Updated

Assembly Biosciences (ASMB) reported Cash from Financing Activities of $108.74 million for Q2 2026, compared with $357,000 a year earlier.

Analysis

Assembly Biosciences (ASMB) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Assembly Biosciences' Cash from Financing Activities came in at $281.27 million; for FY2025, it was $174.67 million, up 493.1% from FY2024.

  • Cash from Financing Activities has a five-year compound annual growth rate of 87.2% (FY2020 to FY2025).
  • By year, Cash from Financing Activities came in at $29.45 million in FY2024 (+113.1%), $13.82 million in FY2023, $614,000 in FY2022 (-98.8%) and $53.06 million in FY2021 (+598.3%).
  • Five-year quarterly Cash from Financing Activities spans a low of $134,000 in Q2 2023 and a high of $171.93 million in Q3 2025.
  • Year over year, Cash from Financing Activities gained in 1 of the last four quarters, with an average decline of 50.5%.
  • The high point for year-over-year Cash from Financing Activities in five years was Q4 2024 (growth of 84.9%); the low point was Q4 2025 (a decline of 97.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $149,000 (Q1 2026), $456,000 (Q4 2025) and $171.93 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Assembly Biosciences 466.28 Mn -561.34 Mn - 108.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 108.74 Mn
Mar 31, 2026 149,000.00
Dec 31, 2025 456,000.00
Sep 30, 2025 171.93 Mn
Jun 30, 2025 357,000.00
Mar 31, 2025 1.92 Mn
Dec 31, 2024 17.00 Mn
Jun 30, 2024 12.45 Mn
Dec 31, 2023 9.19 Mn
Jun 30, 2023 134,000.00
Mar 31, 2023 4.49 Mn
Dec 31, 2022 437,000.00
Jun 30, 2022 177,000.00
Dec 31, 2021 2.71 Mn
Sep 30, 2021 10.06 Mn
Jun 30, 2021 6.16 Mn
Mar 31, 2021 34.14 Mn
Dec 31, 2020 5.69 Mn
Sep 30, 2020 843,000.00
Jun 30, 2020 950,000.00
API Access

Assembly Biosciences Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ASMB&period=max&api_key=YOUR_API_KEY